Cannara Biotech Inc. (8CB0.F)

0.4820 +0.0100 (+2.12%) At close: 08:05AM CEST

Cannara Biotech Inc.

333 Decarie Blvd.
Suite 200
Saint-Laurent, QC H4N 3M9
Canada
514-543-4200
https://cannara.ca

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zohar Krivorot	CEO & Chairman	203.46k	N/A	1977
Mr. Nicholas Sosiak C.A., CPA	Chief Financial Officer	162.77k	N/A	N/A
Mr. Avi Krivorot	Chief Technology Officer	203.46k	N/A	N/A
Mr. Anthony Manouk	VP of Compliance & GM	108.51k	N/A	N/A
Mr. Brian Sherman	General Counsel & VP Legal Affairs	N/A	N/A	N/A
Mr. David Abitbol	Vice President of Marketing	N/A	N/A	N/A
Scott Carroll	Vice President of Marketing & Sales	N/A	N/A	N/A
Ms. France Landry	Vice President of Human Resources	N/A	N/A	N/A
Ms. Julia Bouvet	Chief of Staff	N/A	N/A	N/A
Etienne Ledoux	Executive Officer	203.46k	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Corporate governance

Cannara Biotech Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.